Net delta exposure for Allogene Therapeutics Inc (ALLO) options was $542.99K per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $501.06K.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for ALLO, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for ALLO, 2026-11-20(m), calls & puts
Net Delta Exposure by Expiration
Showing results for ALLO, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
ALLO Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is ALLO delta exposure positive or negative?
Allogene Therapeutics net delta exposure was positive on Nov 4, 2026, at $542.99K. It has been positive on 20 of the last 20 trading days.
How has ALLO delta exposure changed recently?
Allogene Therapeutics net delta exposure went from $501.06K on Oct 7, 2026 to $542.99K on Nov 4, 2026. See the ALLO delta exposure history for a longer view.
What is Allogene Therapeutics Inc?
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases.